Accendra Health named in NYSE delisting notice
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
25-NSE
Rhea-AI Filing Summary
Accendra Health Inc. (ACH) is named in a Form 25 notification concerning removal of its common stock from listing and registration on the New York Stock Exchange. The notice is under Section 12(b) of the Securities Exchange Act and includes language addressing voluntary withdrawal from the exchange.
Key Terms
Section 12(b)
1 terms
Section 12(b) regulatory
"removal from listing and/or registration under Section 12(b)"
Section 12(b) of the U.S. Securities Exchange Act requires securities listed on a national stock exchange to be registered with the U.S. Securities and Exchange Commission (SEC) and to follow regular public reporting and disclosure rules. For investors, a 12(b) listing generally means more routine financial updates, regulatory oversight and easier buying and selling—like a storefront that must display its inventory and prices, making it simpler to inspect and trade the product.
AI-generated analysis. How Rhea-AI works. Not financial advice.